Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs Vital Farms Inc — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B), while Vital Farms Inc trades at $9.45 (market cap $396.69M). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 146.6× Vital Farms Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.36% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days and Vital Farms Inc for 14 Days on average.
| TAK | VITL | |
|---|---|---|
Market Cap | $58.16B | $396.69M |
Volume | 2,467,530 | 1,219,207 |
Sector | Health | Consumer Staples |
52-Week High | $19.05 | $43.68 |
52-Week Low | $13.23 | $8.28 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $86.04B | $483.70M |
Dividend Yield | 3.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Vital Farms (VITL) trades at $9.24, down 1.7% on the day, amid a bearish technical signal and challenging fundamentals. Recent earnings show volatility with a Q2 2026 loss of $0.47 per share, though it slightly beat expectations, while revenue declined 10% year-over-year in that quarter. The company faces pressure from egg pricing and oversupply, as noted in recent news, but maintains a 'Buy' consensus from analysts with a $13.11 price target.
The outlook is mixed: strong analyst support and potential strategic options like a sale offer upside, but weak profitability margins and cash flow concerns pose significant risks. Investors should weigh the company's market position against ongoing industry headwinds and execution challenges in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
